239 related articles for article (PubMed ID: 25060125)
21. Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice.
Techatraisak K; Hestiantoro A; Ruey S; Banal-Silao MJ; Kim MR; Seong SJ; Thaufik S; Ahlers C; Shin SY; Lee BS
BMC Womens Health; 2019 May; 19(1):68. PubMed ID: 31096979
[TBL] [Abstract][Full Text] [Related]
22. Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission.
Leonardo-Pinto JP; Benetti-Pinto CL; Cursino K; Yela DA
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():108-111. PubMed ID: 28231497
[TBL] [Abstract][Full Text] [Related]
23. Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study.
Angioni S; Nappi L; Pontis A; Sedda F; Luisi S; Mais V; Melis GB
Gynecol Endocrinol; 2015 May; 31(5):406-8. PubMed ID: 25776993
[TBL] [Abstract][Full Text] [Related]
24. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.
Cosson M; Querleu D; Donnez J; Madelenat P; Konincks P; Audebert A; Manhes H
Fertil Steril; 2002 Apr; 77(4):684-92. PubMed ID: 11937116
[TBL] [Abstract][Full Text] [Related]
25. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of endometriosis with dienogest: preliminary report].
Kamiński K; Fiegler P; Marr J; Moore C
Ginekol Pol; 2001 May; 72(5):299-304. PubMed ID: 11526761
[TBL] [Abstract][Full Text] [Related]
27. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain.
Muzii L; Galati G; Di Tucci C; Di Feliciantonio M; Perniola G; Di Donato V; Benedetti Panici P; Vignali M
Gynecol Endocrinol; 2020 Jan; 36(1):81-83. PubMed ID: 31304853
[TBL] [Abstract][Full Text] [Related]
28. Dienogest in the treatment of endometriosis: systematic review.
Andres Mde P; Lopes LA; Baracat EC; Podgaec S
Arch Gynecol Obstet; 2015 Sep; 292(3):523-9. PubMed ID: 25749349
[TBL] [Abstract][Full Text] [Related]
29. Long-term therapy with dienogest or other oral cyclic estrogen-progestogen can reduce the need for ovarian endometrioma surgery.
Ferrari F; Epis M; Casarin J; Bordi G; Gisone EB; Cattelan C; Rossetti DO; Ciravolo G; Gozzini E; Conforti J; Cromi A; Laganà AS; Ghezzi F; Odicino F
Womens Health (Lond); 2024; 20():17455057241252573. PubMed ID: 38738634
[TBL] [Abstract][Full Text] [Related]
30. Dienogest: a new therapeutic agent for the treatment of endometriosis.
Harada T; Taniguchi F
Womens Health (Lond); 2010 Jan; 6(1):27-35. PubMed ID: 20001868
[TBL] [Abstract][Full Text] [Related]
31. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial.
Harada T; Momoeda M; Taketani Y; Aso T; Fukunaga M; Hagino H; Terakawa N
Fertil Steril; 2009 Mar; 91(3):675-81. PubMed ID: 18653184
[TBL] [Abstract][Full Text] [Related]
32. Use of dienogest in endometriosis: a narrative literature review and expert commentary.
Murji A; Biberoğlu K; Leng J; Mueller MD; Römer T; Vignali M; Yarmolinskaya M
Curr Med Res Opin; 2020 May; 36(5):895-907. PubMed ID: 32175777
[No Abstract] [Full Text] [Related]
33. Efficacy of dienogest in thinning the endometrium before hysteroscopic surgery.
Kodama M; Onoue M; Otsuka H; Yada-Hashimoto N; Saeki N; Kodama T; Wakasa T; Funato T
J Minim Invasive Gynecol; 2013; 20(6):790-5. PubMed ID: 23830718
[TBL] [Abstract][Full Text] [Related]
34. Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial.
Mabrouk M; Paradisi R; Arena A; Del Forno S; Matteucci C; Zannoni L; Caprara G; Seracchioli R
Gynecol Endocrinol; 2018 May; 34(5):399-403. PubMed ID: 29160135
[TBL] [Abstract][Full Text] [Related]
35. Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents.
Ebert AD; Dong L; Merz M; Kirsch B; Francuski M; Böttcher B; Roman H; Suvitie P; Hlavackova O; Gude K; Seitz C
J Pediatr Adolesc Gynecol; 2017 Oct; 30(5):560-567. PubMed ID: 28189702
[TBL] [Abstract][Full Text] [Related]
36. High-dose pilot study with the novel progestogen dienogestin patients with endometriosis.
Schindler AE; Christensen B; Henkel A; Oettel M; Moore C
Gynecol Endocrinol; 2006 Jan; 22(1):9-17. PubMed ID: 16522528
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical Analysis of the Effect of Dienogest on Ovarian Endometriotic Cysts.
Nguyen TT; Hachisuga T; Urabe R; Ueda T; Kurita T; Kagami S; Kawagoe T; Hisaoka M
J UOEH; 2016; 38(4):271-278. PubMed ID: 27980309
[TBL] [Abstract][Full Text] [Related]
38. Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study.
Heinemann K; Imthurn B; Marions L; Gerlinger C; Becker K; Moehner S; Faustmann T
Adv Ther; 2020 May; 37(5):2528-2537. PubMed ID: 32301063
[TBL] [Abstract][Full Text] [Related]
39. Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study.
Cho B; Roh JW; Park J; Jeong K; Kim TH; Kim YS; Kwon YS; Cho CH; Park SH; Kim SH
Reprod Sci; 2020 Mar; 27(3):905-915. PubMed ID: 32052358
[TBL] [Abstract][Full Text] [Related]
40. Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside.
Laganà AS; Vitale SG; Granese R; Palmara V; Ban Frangež H; Vrtačnik-Bokal E; Chiofalo B; Triolo O
Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):593-596. PubMed ID: 28537213
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
